GeoVax Labs. (GOVX-OTC) Reports Promising Results for Lassa Fever Vaccine
Promising Results Reported for GeoVax's Lassa Fever Vaccine GeoVax announced today a significant step forward ...
New Research Released on GeoVax Labs, Inc. (GOVX-OTC)
An Executive Informational Overview (EIO) is now available on clinical-stage biotechnology company, GeoVax, ...
ASCO and IMS Health: Trends in the Cancer Care Market
Tomorrow kicks off one of the year’s largest oncology conferences: the American Society of Clinical Oncology ...
TapImmune's New State-of-the-Art Lab Facilities and Office Space
We recently received an update from TapImmune Inc. (TPIV-OTC.BB) regarding the Company's newly acquired ...